Technical Analysis for GSGTF - Gensight Biologics Sa

Grade Last Price % Change Price Change
grade B 3.2 106.45% 1.6500
GSGTF closed up 106.45 percent on Wednesday, December 11, 2019, on 3.29 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
See historical GSGTF trend table...

Date Alert Name Type % Chg
Volume Surge Other 0.00%
Gapped Up Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Volume Surge Other 106.45%
Narrow Range Bar Range Contraction 106.45%
Gapped Up Strength 106.45%
Narrow Range Bar Range Contraction 120.69%
Gapped Up Strength 120.69%
New 52 Week Closing Low Bearish 122.22%
Hot IPO Pullback Bullish Swing Setup 122.22%
Older signals for GSGTF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye, and central nervous system. The company develops its products through gene therapy-based approach with technology platforms of mitochondrial targeting sequence and optogenetics. Its lead product candidates include GS010, an AAV2 containing the human wild-type ND4 gene, which is in Phase III clinical trials for the treatment of leber hereditary optic neuropathy associated with mutation in the ND4 gene; and GS030 that comprises a gene encoding photoactivatable channelrhodopsin for the treatment of reinitis pigmentosa and geographic atrophy in dry age-related macular degeneration. The company also develops products that are preclinical stage targeting ophthalmic and neurodegenerative diseases. GenSight Biologics S.A. was founded in 2012 and is headquartered in Paris, France.
Biotechnology RTT Biopharmaceutical Life Sciences Biology Gene Therapy Technology Platforms Its Products Macular Degeneration Its Senescence

Is GSGTF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News


Indicator Value
52 Week High 3.6
52 Week Low 1.44
Average Volume 13,072
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 0.0000
10-Day Moving Average 1.9978
Average True Range 0.0000
ADX 0.0
+DI 0.0000
-DI 0.0000
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0000
Lower Bollinger Band 0.0000
Percent B (%b) 0.0
BandWidth 0.0000
MACD Line 0.0745
MACD Signal Line 0.0149
MACD Histogram 0.0596
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.4700
Resistance 3 (R3) 3.4400 3.3200 3.4250
Resistance 2 (R2) 3.3200 3.2512 3.3350 3.4100
Resistance 1 (R1) 3.2600 3.2088 3.2900 3.2900 3.3950
Pivot Point 3.1400 3.1400 3.1550 3.1550 3.1400
Support 1 (S1) 3.0800 3.0712 3.1100 3.1100 3.0050
Support 2 (S2) 2.9600 3.0288 2.9750 2.9900
Support 3 (S3) 2.9000 2.9600 2.9750
Support 4 (S4) 2.9300